Net profit of Emcure Pharmaceuticals rose 43.64% to Rs 206.95 crore in the quarter ended June 2025 as against Rs 144.08 crore during the previous quarter ended June 2024. Sales rose 15.72% to Rs 2100.54 crore in the quarter ended June 2025 as against Rs 1815.14 crore during the previous quarter ended June 2024.
Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
Sales | 2100.54 | 1815.14 | 16 |
OPM % | 19.84 | 18.53 | - |
PBDT | 393.71 | 301.00 | 31 |
PBT | 294.26 | 207.41 | 42 |
NP | 206.95 | 144.08 | 44 |